A share price of Fulgent Genetics Inc [FLGT] is currently trading at $20.78, up 13.18%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The FLGT shares have gain 18.27% over the last week, with a monthly amount glided 7.72%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Fulgent Genetics Inc [NASDAQ: FLGT] stock has seen the most recent analyst activity on August 05, 2025, when UBS upgraded its rating to a Buy but kept the price target unchanged to $30 for it. Previously, UBS started tracking the stock with Neutral rating on December 07, 2023, and set its price target to $35. On December 08, 2022, downgrade downgraded it’s rating to Neutral and revised its price target to $40 on the stock. Raymond James started tracking the stock assigning a Outperform rating and suggested a price target of $45 on November 18, 2022. Credit Suisse initiated its recommendation with a Outperform and recommended $65 as its price target on August 25, 2022.
Fulgent Genetics Inc experienced fluctuations in its stock price throughout the past year between $14.57 and $25.00. Currently, Wall Street analysts expect the stock to reach $25 within the next 12 months. Fulgent Genetics Inc [NASDAQ: FLGT] shares were valued at $20.78 at the most recent close of the market. An investor can expect a potential return of 20.31% based on the average FLGT price forecast.
Analyzing the FLGT fundamentals
Trailing Twelve Months sales for Fulgent Genetics Inc [NASDAQ:FLGT] were 303.22M which represents 15.17% growth. Gross Profit Margin for this corporation currently stands at 0.4% with Operating Profit Margin at -0.24%, Pretax Profit Margin comes in at -0.2%, and Net Profit Margin reading is -0.17%. To continue investigating profitability, this company’s Return on Assets is posted at -0.04, Equity is -0.05 and Total Capital is -0.06. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Fulgent Genetics Inc [NASDAQ:FLGT] is 6.01. In addition, the Quick Ratio stands at 6.01 and the Cash Ratio stands at 1.23. Considering the valuation of this stock, the price to sales ratio is 2.10, the price to book ratio is 0.57.
Transactions by insiders
Recent insider trading involved Gao Hanlin, Chief Scientific Officer, that happened on Jun 02 ’25 when 754.0 shares were sold. President and COO, Xie Jian completed a deal on Jun 02 ’25 to sell 1135.0 shares. Meanwhile, Officer Xie Jian bought 1135.0 shares on Jun 02 ’25.
